Hank Greely

When the state & ‘rogue’ scientists collide: case of China & CRISPR baby guy He Jiankui (贺建奎)

He-Jiankui-贺建奎

What happens next to He Jiankui (贺建奎) or as some people now refer to him, the “CRISPR baby guy”? China has a challenging situation to resolve here, but such conflicts between scientists and governments have happened regularly in history. When scientists go “rogue” (i.e. don’t conform to norms or ethical standards in an extreme way or …

When the state & ‘rogue’ scientists collide: case of China & CRISPR baby guy He Jiankui (贺建奎) Read More »

Trying to connect the dots on CRISPR baby story paints a dark, cloudy picture

connect-the-dots

When I was a little kid I played this game called “connect the dots” or “dot-to-dot”, where you draw a line from dot-to-dot in numerical order and at some point a picture starts to emerge. I think kids and even some adults still play this today. They even come in extreme versions with hundreds or …

Trying to connect the dots on CRISPR baby story paints a dark, cloudy picture Read More »

Weekend reads: stem cells, organoids, cancer, CRISPR & a tiger named Igor

Tiger

What are your typical weekend reads? If you are a scientist, they might often include a great deal of science. I always hope I can find time for reading for pleasure too, but about as close as I get to that is the New York Times on Sunday. Here are some recommended science reads for …

Weekend reads: stem cells, organoids, cancer, CRISPR & a tiger named Igor Read More »

Hope & hype on unpublished Huntington’s Disease trial splashy news

Huntingtons-brain-MRI

Some conditions like Huntington’s Disease are so bad and there are no treatments such that any bit of encouraging news can be cause for legitimate excitement, but at the same time things can go too far potentially, especially if there is news coverage not backed up by a published paper or some other definitive source …

Hope & hype on unpublished Huntington’s Disease trial splashy news Read More »

New #CRISPR updates: Editas to go public, patent issues, dragons & more

CRISPR-dragon

A lot has been going on in the CRISPR world. Here are some key CRISPR updates. Editas has filed the paperwork on the road to going public as a company. Such an IPO, should it come to fruition, could raise billions of dollars. Will the other CRISPR companies like Caribou and CRISPR Therapeutics follow suit? Simplistically, …

New #CRISPR updates: Editas to go public, patent issues, dragons & more Read More »

Congress: FDA should consult religious experts on embryo CRISPR

Crystal_Structure_of_Cas9_in_Complex_with_Guide_RNA_and_Target_DNA

The US Congress recently held its first hearing on human germline genetic modification. The meeting included CRISPR-Cas9 pioneer Jennifer Doudna (see video here) on the panel. See image of Cas9 structure from Wikipedia. CRISPR-Cas9 is a powerful, strikingly efficient tool for genetic engineering of cells and whole organisms. Now Republican congressional leaders have included a …

Congress: FDA should consult religious experts on embryo CRISPR Read More »

Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next?

CRISPR-primates

A decade ago I wrote an article in the journal Nature Biotechnology about the rise of a new gene editing technology called zinc finger nucleases (ZNF). It was one of those “drumbeat” discoveries: at the time, my sense was it would revolutionize how we deliver genes to cells and tissues, and profoundly change the way …

Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next? Read More »

Stanford Human Germline Modification Meeting: Medicine, Science, Ethics, & Law

Greely_Hank

Last Thursday I participated in a meeting at Stanford Law School on human germline genetic modification hosted by Hank Greely (pictured at left), Professor of Law and Genetics at Stanford. The meeting was entitled, “Human Germline Modification: Medicine, Science, Ethics, and Law”. The panel included in addition to Hank and me, the following speakers: Marcy Darnovsky, Executive Director of …

Stanford Human Germline Modification Meeting: Medicine, Science, Ethics, & Law Read More »

Hank Greely Human Germline Modification Post

Week-8-Cover

Hank Greely over at The Center for Law and Biosciences at Stanford Law School was one of the participants in the recent Napa meeting on approaches to human germline genetic modification. Hank was also one of the authors on the resulting position paper in Science with David Baltimore as first author (here). Now Hank, pictured below, …

Hank Greely Human Germline Modification Post Read More »